Physician profile
Pamela Wayne Wright
NPI 1376538892
$2,546.26
in general payments reported to CMS, 2019-2025
17 companies · $292 in 2025
The $292 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $441 · 2022: $478 · 2023: $523 · 2024: $812 · 2025: $292.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,404 · Education: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,404.06 |
| Education | $223.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $636.93 | 2021-2025 | Airsupra, Fasenra, Tezspire |
| Genentech USA, INC. | $498.85 | 2021-2024 | Xolair |
| Amgen INC. | $231.04 | 2021-2025 | Tezspire |
| Genzyme Corporation | $228.52 | 2021-2024 | |
| Regeneron Healthcare Solutions, INC. | $199.09 | 2022-2024 | Dupixent |
| Glaxosmithkline, LLC. | $159.74 | 2021-2025 | Nucala, Trelegy Ellipta |
| Takeda Pharmaceuticals U.S.A., INC. | $141.49 | 2021-2024 | Takhzyro, Hyqvia, Cuvitru |
| Sanofi-Aventis U.S. LLC | $99.95 | 2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $92.48 | 2021-2022 | |
| Pharming Healthcare, INC. | $56.46 | 2025 | Ruconest |
| Novartis Pharmaceuticals Corporation | $47.11 | 2025 | |
| Abbvie INC. | $38.77 | 2021-2022 | |
| Csl Behring | $34.83 | 2024 | Haegarda |
| Ars Pharmaceuticals Operations, INC. | $25.93 | 2025 | Neffy |
| Kaleo, INC. | $23.64 | 2023 | Auvi-Q |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biocryst US Sales Co., LLC | $18.97 | 2023 | Orladeyo |
| Hospira, INC. | $12.46 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Pamela Wright listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.